Transparency Market Research

Global Cancer Immunotherapy Market Is Expected to Grow by Leaps and Bounds in the Near Future

Transparency Market Research Report Added "Cancer Immunotherapy Market" to its database.

 

Albany, NY -- (SBWIRE) -- 04/04/2016 -- Transparency Market Research is set to publish a new research report that offers a detailed view of the global cancer immunotherapy market. The report, titled "Cancer Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023", gives an accurate analysis of the market. The report highlights the strengths, weaknesses, threats, and opportunities in this market. Furthermore, it presents historical data and correlates it with the forecast to map the trajectory of the global cancer immunotherapy market in the coming years.

According to the World Cancer Research Fund International (WCRFI), about 12.7 mn people across the globe were suffering from cancer in 2008. Researchers estimate this number will reach about 21 mn by 2030. On the backdrop of these alarming figures, the global cancer immunotherapy market is expected to grow by leaps and bounds in the near future.

The high success rate of cancer immunotherapy will also help the market log a positive growth rate, as a growing number of healthcare units will adopt the therapy for treating cancer. Cancer immunotherapy will also witness a growing number of investments and soaring research and development activities that will add to the growing contribution of this market to the global economy. Development of several cancer vaccines and monoclonal antibodies will also encourage medical practitioners and oncologists to opt for promising cancer immunotherapy products.

The cancer immunotherapy market is inclusive of non-specific immunotherapy, cancer vaccines therapy, and monoclonal antibodies therapy. Each of these components plays an important and specific role in treating cancer. For instance, non-specific immunotherapies push the immune system so that it attacks the cancer cells. Cancer vaccines, otherwise known as cell-based therapy, refer to injecting certain substances in the patient's body to prompt an immune response to the cancer. Monoclonal antibodies are identical immune cells that are versions of unique parent cells. These antibodies are known to treat cancer by attacking specific parts of the maligned cells in the body.

Download Brochure: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4312

Some of the important players in the global cancer immunotherapy market are AstraZeneca, Bristol-Myers Squibb, Viralytics, Ltd., GlaxoSmithKline Pharmaceuticals Limited, Medivation, Inc., Celgene Corp., Advaxis, Inc., Merck & Co., Novartis Pharmaceuticals Corporation, F. Hoffmann-La Roche Ltd. and plc. The research report has analyzed this market using SWOT analysis and Porter's five forces analysis to examine the key factors impacting the management styles of the these companies. The research analysts have also explained the competitive landscape of this market by sharing details pertaining to the financial overview, business and marketing strategies, research and development activities, and investment outlook of the key companies for the near future.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/